Hansa Biopharma AB (publ) (STO:HNSA)
Sweden
· Delayed Price · Currency is SEK 24.20
-0.18 (-0.74%)
Jun 5, 2025, 5:29 PM CET
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 1.64 billion as of June 6, 2025. Its market cap has decreased by -32.78% in one year.
Market Cap
1.64B
Enterprise Value
2.41B
Revenue
181.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.20
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 1.64B, an increase of 5,243.47%. That is a compound annual growth rate of 26.15%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 105.51B |
| Sectra AB | 68.36B |
| Getinge AB | 51.65B |
| Asker Healthcare Group AB | 40.83B |
| Camurus AB | 37.44B |
| Medicover AB | 36.16B |
| AddLife AB | 23.37B |
| Vimian Group AB | 22.37B |